Table 4.
Frequency of different medications used for treating symptomatic COVID-19 and their outcomes (n = 99).
| Frequency (n) | Percentage (%) | |
|---|---|---|
| Required medical therapy administered to the patient in-hospital | ||
| Supplemental oxygen | 17 | 17.17 |
| Steroids/NSAIDs | 11 | 11.11 |
| Bronchodilators | 10 | 10.1 |
| Hydroxychloroquine | 2 | 2.02 |
| Oseltamivir | 1 | 1.01 |
| Lopinavir/ritonavir | 2 | 2.01 |
| Antibiotics | 19 | 19.19 |
| Duration on antibiotics (d), mean (SD) (n = 15) | 5.9 (3.13) | |
| Pediatric intensive care admission | 9 | 9.09 |
| Pediatric intensive care length of stay (d), median (IQR), (n = 9) | 9.5 (17.75) | |
| Required endotracheal intubation | 6 | 6.06 |
| Duration on mechanical ventilator (d), median (IQR) (n = 6) | 7 (11.5) | |
| Outcomes | ||
| Fully recovered | 96 | 96.96 |
| Recovered with sequelae | 1 | 1.01 |
| Death | 2 | 2.02 |
COVID-19, coronavirus disease; IQR, interquartile range; NSAID, non-steroidal anti-inflammatory drug; SD, standard deviation.